FAA Approves J&J COVID Vaccine for Safety-Sensitive Roles | Aero-News Network
Aero-News Network
RSS icon RSS feed
podcast icon MP3 podcast
Subscribe Aero-News e-mail Newsletter Subscribe

Airborne Unlimited -- Most Recent Daily Episodes

Episode Date

Airborne-Monday

Airborne-Tuesday

Airborne-Wednesday Airborne-Thursday

Airborne-Friday

Airborne On YouTube

Airborne-Unlimited-05.13.24

Airborne-NextGen-05.07.24

Airborne-Unlimited-05.08.24 Airborne-FlightTraining-05.09.24

Airborne-Unlimited-05.10.24

Sat, Dec 31, 2022

FAA Approves J&J COVID Vaccine for Safety-Sensitive Roles

Recipients Required to Wait 48 Hours Prior to Performing Duties

The FAA has followed through on a COVID-19 vaccination approval, now allowing the Johnson & Johnson (Janssen) COVID-19 vaccine for pilots, controllers, and similar roles. 

The news honors an Emergency Use Authorization from the U.S. Food and Drug Administration. The FAA has determined that the vaccine is allowable under the conditions of their FAA-issued airman medical certification. FAA and contract air traffic controllers, who are subject to FAA medical clearance, may also receive the vaccine. That shot comes with a caveat just like it did last year, requiring a short pause before resuming work duties.

"To maintain the highest level of safety in the National Airspace System," the announcement read. "The FAA will require the affected recipients of this single-dose vaccine to wait 48 hours before conducting safety-sensitive aviation duties, such as flying or controlling air traffic. The waiting period, which accounts for potential side effects, applies to those holding an Airman Medical Certificate issued under 14 CFR Part 67 or a Medical Clearance issued under FAA Order 3930.3C."

The FAA says that their staff of medical professionals will "continuously monitor the initial distribution of the Johnson & Johnson COVID-19 vaccine and will adjust the recommendations as needed," leaving enough slack on the table in case of changing conditions. The speed of fresh COVID strains and vaccine formulations may have kept the administration on their toes after 2021, prompting them to remain ready for any changes in the pipeline. They say that they will "evaluate additional vaccines as they receive FDA emergency use authorization and will advise pilots and air traffic controllers of any required waiting periods".

For now, the J&J requirements could be seen to be a fair template of what to expect for other brands, as it falls perfectly in line with similar 48-hour waiting periods for its competing Moderna and Pfizer products. The FAA notes that similar waiting periods apply to other vaccines too, like tuberculosis and typhoid.

FMI: www.faa.gov

Advertisement

More News

Sierra Space Repositions Dream Chaser for First Mission

With Testing Soon Complete, Launch Preparations Begin in Earnest Sierra Space's Dream Chaser has been put through the wringer at NASA's Glenn Armstrong Test Facility in Ohio, but w>[...]

ANN's Daily Aero-Term (05.10.24): Takeoff Roll

Takeoff Roll The process whereby an aircraft is aligned with the runway centerline and the aircraft is moving with the intent to take off. For helicopters, this pertains to the act>[...]

Aero-News: Quote of the Day (05.10.24)

“We’re proud of the hard work that went into receiving this validation, and it will be a welcome relief to our customers in the European Union. We couldn’t be mor>[...]

Aero-News: Quote of the Day (05.11.24)

"Aircraft Spruce is pleased to announce the acquisition of the parts distribution operations of Wag-Aero. Wag-Aero was founded in the 1960’s by Dick and Bobbie Wagner in the >[...]

ANN's Daily Aero-Term (05.11.24): IDENT Feature

IDENT Feature The special feature in the Air Traffic Control Radar Beacon System (ATCRBS) equipment. It is used to immediately distinguish one displayed beacon target from other be>[...]

blog comments powered by Disqus



Advertisement

Advertisement

Podcasts

Advertisement

© 2007 - 2024 Web Development & Design by Pauli Systems, LC